The analysis showed that there were statistically significant changes in the ncRNA profile of KRAS-mutated CRC as a result of reovirus treatment, with seven ncRNAs, one miRNA, and one snoRNA having a fold change difference of 2 or greater due to the reovirus treatment (Figure 1). This evidence concerns the gene KRAS and colorectal carcinoma.